Scandinavian ChemoTech: Strategic update for the US veterinary market - Redeye

Redeye comments on Scandinavian ChemoTech's strategy update. Scandinavian ChemoTech is transitioning from a distributor-based business model to an in-house approach for the US animal care segment. Redeye raises its valuation.

Länk till analysen i sin helhet: https://www.redeye.se/research/936143/scandinavian-chemotech-strategic-update-for-the-us-veterinary-market?utm_source=finwire&utm_medium=RSS